MarketCapExport financials
Bioceres Crop Solutions Corp. (BIOX)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Bioceres Crop Solutions Corp. Income Statement 2025-2011 | BIOX
Brief overview of income trends at Bioceres Crop Solutions Corp.
The figures are compared over a five-year interval. According to figures from Bioceres Crop Solutions Corp., revenue changed from 173 million dollars to 335 million dollars over five years. The five-year change reached +93.6%, while CAGR stood at 14.1%. The company expanded its sales base at a healthy rate.
The five-year change in gross profit reached +65.6%: from $79.5 million to $132 million. The cost base moved against the top-line trend and weighed on the gross result. At the margin level, the figure shifted from 45.9% to 39.3%. Weakening gross profitability reduces the quality of the top-line trend.
EBITDA was $39.1 million at the beginning and −$2.2 million at the end of the period (−105.7%). The operating result developed less favorably than sales. EBITDA margin moved from 22.6% to −0.7%. Operating return per unit of revenue declined.
The net financial result changed from 3.4 million dollars to −58.8 million dollars. The move from profit to loss indicates a material deterioration in final efficiency.
Over the period, capitalization shifted from 296 million dollars to 105 million dollars (−64.6%). The market has not yet confirmed the improvement in fundamentals.
Conclusion
The financial trajectory is weak and requires a cautious interpretation. The constructive conclusion rests on revenue expansion. The weaker side of the profile includes lower net income, declining capitalization and pressure on operating profitability. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement Bioceres Crop Solutions Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
105 M | 400 M | 757 M | 469 M | 494 M | 296 M | 18.1 M | 158 M | - | - | - | - | - | - | - |
Shares |
63.2 M | 62.8 M | 62.1 M | 42.3 M | 39.2 M | 36.1 M | 3.2 M | 28.1 M | - | - | - | - | - | - | - |
Historical Prices |
1.66 | 6.36 | 12.2 | 11.1 | 12.6 | 8.2 | 5.66 | 5.61 | - | - | - | - | - | - | - |
Net Income |
-58.8 M | 7.29 M | 20.2 M | -3.91 M | -3.82 M | 3.36 M | 742 K | -11 M | - | - | - | - | - | - | - |
Revenue |
335 M | 465 M | 420 M | 335 M | 210 M | 173 M | 161 M | 134 M | - | - | - | - | - | - | - |
Cost of Revenue |
203 M | 278 M | 235 M | 208 M | 119 M | 93.6 M | 87 M | 77.1 M | - | 30.6 M | - | - | - | - | - |
Gross Profit |
132 M | 187 M | 185 M | 126 M | 90.9 M | 79.5 M | 73.6 M | 56.4 M | - | - | - | - | - | - | - |
Operating Income |
-2.24 M | 45.9 M | 54.2 M | 39.9 M | 38.4 M | 39.1 M | 32.1 M | 15.7 M | - | 207 K | - | - | - | - | - |
EBITDA |
-2.24 M | 45.9 M | 54.2 M | 39.9 M | 38.4 M | 39.1 M | 32.1 M | 15.7 M | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | 42.8 M | - | 38.5 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
123 M | 124 M | 113 M | 77.5 M | 47.6 M | - | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Bioceres Crop Solutions Corp.
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
63.5 M | 63.4 M | - | 62.8 M | 63.2 M | 62.9 M | - | 62.8 M | 62.8 M | 62.8 M | - | 62 M | 62.1 M | - | - | - | - | 42.4 M | - | - | - | 39 M | - | - | - | 36.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-182 M | -7.45 M | - | -1.59 M | -58.8 M | -6.2 M | - | 9.78 M | 7.29 M | -2.68 M | - | 27.5 M | 20.2 M | - | - | - | - | 5.34 M | - | - | - | 1.8 M | - | - | - | 12.6 M | - | - | - | 11.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
73.8 M | 77.6 M | - | 60.6 M | 335 M | 93.3 M | - | 341 M | 465 M | 117 M | - | 92.5 M | 420 M | - | - | - | - | 92.7 M | - | - | - | 48.7 M | - | - | - | 63 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
47.2 M | 41.3 M | - | 36.7 M | 203 M | 55.8 M | - | 41.3 M | 278 M | 71.6 M | - | 36.1 M | 235 M | - | - | - | - | 55.3 M | - | - | - | 25.1 M | - | - | - | 33 M | - | - | - | 33.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
26.7 M | 36.3 M | - | 23.8 M | 132 M | 37.5 M | - | 139 M | 187 M | 45 M | - | 142 M | 185 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
7.52 M | 7.21 M | - | 933 K | -2.24 M | 2.37 M | - | 13.2 M | 45.9 M | 5.29 M | - | 29.9 M | 54.2 M | - | - | - | - | 17.7 M | - | - | - | 11.5 M | - | - | - | 19.6 M | - | - | - | 19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
7.52 M | 7.21 M | - | 933 K | -2.24 M | 2.37 M | - | 13.2 M | 45.9 M | 5.29 M | - | 29.9 M | 54.2 M | - | - | - | - | 17.7 M | - | - | - | 11.5 M | - | - | - | 19.6 M | - | - | - | 19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
17.1 M | 23.1 M | - | 26.2 M | 123 M | 30.2 M | - | 27.1 M | 124 M | 33.9 M | - | 24 M | 113 M | - | - | - | - | 18.8 M | - | - | - | 11.2 M | - | - | - | 10.5 M | - | - | - | 10.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Bioceres Crop Solutions Corp. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Agricultural inputs industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Arcadia Biosciences
RKDA
|
$ 0.16 | 2.94 % | $ 219 K |  USA |
 |
Origin Agritech Limited
SEED
|
$ 0.93 | 0.49 % | $ 6.97 M |  China |
 |
The Scotts Miracle-Gro Company
SMG
|
$ 55.93 | 0.09 % | $ 3.22 B | USA |
 |
CVR Partners, LP
UAN
|
$ 127.08 | -0.27 % | $ 1.34 B | USA |
 |
Intrepid Potash
IPI
|
$ 31.2 | -2.13 % | $ 406 M | USA |
 |
Nutrien Ltd.
NTR
|
$ 68.12 | -1.3 % | $ 33.1 B |  Canada |
 |
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M | China |
 |
Акрон
AKRN
|
- | - | - |  Russia |
 |
ФосАгро
PHOR
|
- | - | - | Russia |
 |
Corteva
CTVA
|
$ 12.72 | -1.47 % | $ 8.65 B | USA |
 |
ICL Group Ltd
ICL
|
$ 4.77 | -2.05 % | $ 6.16 B |  Israel |
 |
American Vanguard Corporation
AVD
|
$ 1.06 | -0.47 % | $ 30.1 M | USA |
 |
CF Industries Holdings
CF
|
$ 116.3 | -1.35 % | $ 18.9 B | USA |
 |
FMC Corporation
FMC
|
$ 5.03 | -5.27 % | $ 630 M | USA |
 |
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | USA |
 |
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | USA |
 |
The Mosaic Company
MOS
|
$ 17.68 | -0.98 % | $ 5.61 B | USA |